Evidence map›Paper›PMID 42423323›Full record

ArticleJACC. Case reports2026

Ventricular Volumetric Changes After Transcatheter Tricuspid Valve Replacement in a Heart Transplant Recipient.

Denizhan Ozdemir, Mandeep Singh, Farhan A Bajwa, Jean-Pierre Iskandar, Elizabeth C Melito, Katherine Kaproth-Joslin, Kazuhiro Hisamoto, Leway Chen, Frederick S Ling

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Denizhan OzdemirUniversity of Rochester Medical Center, Rochester, New York, USA. Electronic address: Denizhan_Ozdemir@URMC.Rochester.edu.
Mandeep SinghUniversity of Rochester Medical Center, Rochester, New York, USA.
Farhan A BajwaUniversity of Rochester Medical Center, Rochester, New York, USA.
Jean-Pierre IskandarUniversity of Rochester Medical Center, Rochester, New York, USA.
Elizabeth C MelitoUniversity of Rochester Medical Center, Rochester, New York, USA.
Katherine Kaproth-JoslinUniversity of Rochester Medical Center, Rochester, New York, USA.
Kazuhiro HisamotoUniversity of Rochester Medical Center, Rochester, New York, USA.
Leway ChenUniversity of Rochester Medical Center, Rochester, New York, USA.
Frederick S LingUniversity of Rochester Medical Center, Rochester, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere tricuspid regurgitation is a common complication after orthotopic heart transplantation (OHT), but transplant recipients are underrepresented in transcatheter trials. Early ventricular volume and ejection fraction changes after transcatheter tricuspid valve replacement (TTVR) in this population remain unclear. CASE SUMMARY: A 62-year-old man with nonischemic cardiomyopathy, and subsequent OHT developed NYHA functional class III symptoms from severe tricuspid regurgitation. Transcatheter edge-to-edge repair was deemed unfeasible because of imaging limitations. Computed tomography demonstrated annular dilation, and TTVR with a 44-mm EVOQUE valve was performed. At 30 days, the valve was well functioning, without significant residual regurgitation or hypoattenuated leaflet thickening. Repeat computed tomography showed reduced biventricular end-diastolic volumes, with increased left ventricular and effective right ventricular ejection fractions. DISCUSSION: This case supports feasibility and early physiologic directional ventricular changes after EVOQUE implantation in an OHT patient. TAKE-HOME MESSAGE: TTVR is safe in OHT recipients, with early favorable changes in biventricular volumes and function.

Indexed as

computed tomography,transcatheter tricuspid valve replacementtricuspid regurgitation,valvular disease

Identifiers

PMID42423323
PMCPMC13350657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.